Does IPILIMUMAB Cause Disseminated intravascular coagulation? 140 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Disseminated intravascular coagulation have been filed in association with IPILIMUMAB (YERVOY). This represents 0.4% of all adverse event reports for IPILIMUMAB.
140
Reports of Disseminated intravascular coagulation with IPILIMUMAB
0.4%
of all IPILIMUMAB reports
70
Deaths
104
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From IPILIMUMAB?
Of the 140 reports, 70 (50.0%) resulted in death, 104 (74.3%) required hospitalization, and 46 (32.9%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 140 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which IPILIMUMAB Alternatives Have Lower Disseminated intravascular coagulation Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN